Fedra Luciano-Mateo Selected Research

Fedra Luciano-Mateo Research Topics

Disease

9	Inflammation (Inflammations) 10/2019 - 01/2013
7	Neoplasms (Cancer) 12/2022 - 02/2013
6	Fatty Liver 07/2022 - 04/2016
5	Obesity 07/2022 - 01/2016
4	Non-alcoholic Fatty Liver Disease 07/2022 - 10/2019
4	Breast Neoplasms (Breast Cancer) 12/2018 - 01/2017
3	Morbid Obesity 07/2022 - 01/2020
2	Weight Loss (Weight Reduction) 01/2021 - 10/2017
2	Liver Diseases (Liver Disease) 01/2021 - 01/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 11/2018
2	Infections 11/2018 - 01/2018
2	Peripheral Arterial Disease 05/2017 - 05/2015
2	Vascular Diseases (Vascular Disease) 05/2017 - 05/2015
2	Insulin Resistance 01/2016 - 01/2013
1	Adenocarcinoma 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Alcoholic Fatty Liver 05/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2019
1	Lung Neoplasms (Lung Cancer) 07/2019
1	Asthenia 12/2018
1	Dermatitis 12/2018
1	Septic Shock (Toxic Shock Syndrome) 11/2018
1	Communicable Diseases (Infectious Diseases) 11/2018
1	Sepsis (Septicemia) 11/2018
1	Renal Insufficiency (Renal Failure) 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Diabetes Mellitus 07/2018
1	Premature Aging 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Diabetes Complications 04/2016
1	Body Weight (Weight, Body) 04/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Atherosclerosis 05/2015
1	Noncommunicable Diseases 01/2014

Drug/Important Bio-Agent (IBA)

8	Aryldialkylphosphatase (Paraoxonase)IBA 10/2019 - 01/2017
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020 - 01/2016
5	AntioxidantsIBA 07/2019 - 05/2015
4	ChemokinesIBA 12/2022 - 01/2013
4	EnzymesIBA 07/2022 - 05/2015
4	CC ChemokinesIBA 01/2020 - 01/2013
4	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2016
3	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2015
2	TOR Serine-Threonine KinasesIBA 07/2022 - 05/2021
2	Adenosine Monophosphate (AMP)IBA 07/2022 - 05/2021
2	Protein Kinases (Protein Kinase)IBA 07/2022 - 05/2021
2	LigandsIBA 01/2020 - 01/2013
2	Galectin 3 (LGALS3)IBA 10/2019 - 05/2017
2	Trace Elements (Biometals)IBA 12/2018 - 07/2018
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	Death Domain ReceptorsIBA 12/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2022
1	Mitogen-Activated Protein KinasesIBA 05/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Ki-67 Antigen (Ki 67 Antigen)IBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	ErbB Receptors (EGF Receptor)IBA 12/2018
1	ElementsIBA 11/2018
1	HDL CholesterolIBA 11/2018
1	MineralsIBA 07/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	Aconitic Acid (Aconitate)IBA 01/2018
1	Drinking WaterIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	CholesterolIBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Triglycerides (Triacylglycerol)IBA 10/2017
1	C-Reactive ProteinIBA 05/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	BiguanidesIBA 01/2016
1	Insulin ReceptorIBA 01/2016
1	Lipid PeroxidesIBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	LipidsIBA 05/2015
1	IridoidsIBA 02/2013
1	Chemokine ReceptorsIBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	CytokinesIBA 01/2013

Therapy/Procedure

3	Gastrectomy 07/2022 - 10/2019
3	Radiotherapy 07/2019 - 01/2017
2	Bariatric Surgery 05/2021 - 01/2020
1	Immunotherapy 12/2022
1	Continuous Renal Replacement Therapy 11/2018
1	Urinary Catheters 01/2018
1	Intraperitoneal Injections 01/2018
1	Therapeutics 01/2018